Group 1 - Clover Health Investments, Corp. reported quarterly earnings of $0.02 per share, exceeding the Zacks Consensus Estimate of a loss of $0.07 per share, and showing improvement from a loss of $0.12 per share a year ago, resulting in an earnings surprise of 128.57% [1] - The company posted revenues of $336.96 million for the quarter ended December 2024, which was 2.02% below the Zacks Consensus Estimate, and a decrease from year-ago revenues of $510.25 million [2] - Clover Health Investments has surpassed consensus EPS estimates in all four of the last quarters, while topping consensus revenue estimates two times during the same period [2] Group 2 - The stock has increased approximately 37.1% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.3% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors to assess future stock performance [4] - The current consensus EPS estimate for the upcoming quarter is -$0.03 on revenues of $389.7 million, and -$0.07 on revenues of $1.53 billion for the current fiscal year [7] Group 3 - The Medical Info Systems industry, to which Clover Health Investments belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The current estimate revisions trend for Clover Health Investments is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

Financial Data and Key Metrics Changes - In 2024, Clover Health achieved adjusted EBITDA profitability, marking a significant milestone for the company [4][19] - Insurance revenue grew by 9% in both Q4 and full year 2024, reaching $331 million and $1.345 billion respectively [15] - The insurance benefit expense ratio improved to 82.8% in Q4 2024 from 87.4% in Q4 2023, while the medical care ratio (MCR) improved to 73.5% from 82.4% year-over-year [15][16] - For the full year 2024, the benefit expense ratio (BER) was 81.2% and MCR was 75.1%, both showing improvements of over 500 basis points year-over-year [16][22] - Adjusted EBITDA for the full year 2024 was over $70 million, a $112 million improvement compared to 2023 [19] Business Line Data and Key Metrics Changes - Clover Health surpassed 100,000 Medicare Advantage members in 2024, achieving a 27% year-over-year growth and a 95% retention rate during the Annual Enrollment Period (AEP) [5][18] - The launch of Counterpart Health, a software business, has begun to show promise with a growing pipeline of external partners [6][11] Market Data and Key Metrics Changes - The company reported strong membership growth primarily from switchers from other Medicare Advantage plans, indicating a competitive advantage in capturing market share [24] - The Medicare Advantage membership is expected to average between 210,000 members in 2025, reflecting a 30% year-over-year growth [20] Company Strategy and Development Direction - Clover Health aims to maintain adjusted EBITDA profitability while investing in new member growth, Clover Assistant technology, and expanding home care services [12][24] - The company is focused on a technology-first care model that enhances care management and reduces costs, positioning itself favorably against traditional models [8][9] - Counterpart Health is seen as a strategic initiative to expand Clover's reach and improve value-based performance [11][29] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to achieve profitable growth and improve clinical outcomes through technology-driven care management [7][8] - The company anticipates strong membership growth in the upcoming AEP season and expects to benefit from a four-star payment year in 2026 [30][31] - Management highlighted the importance of proactive care management in controlling total costs and improving member health outcomes [33] Other Important Information - Clover Health's SG&A expenses increased by 7% year-over-year in Q4 2024, driven by strategic investments for the AEP season [18] - The company ended Q4 2024 with cash and investments totaling $438 million, indicating a strong balance sheet position [19] Q&A Session Summary Question: When can revenue metrics from Counterpart Health be expected in financials? - Management is excited about Counterpart Health but has not provided a timeline for when revenue will be incorporated into financial results, focusing instead on expanding reach and partnerships [35][38] Question: How much of the SG&A increase is related to AEP growth, and what are the expectations for future SG&A? - The growth in SG&A is significantly tied to growth-related expenses, but management expects a 200 basis point improvement in SG&A as a percentage of revenue for 2025 [40][41] Question: Expectations for Q2 growth of the home care arm? - Management emphasized the importance of home care in their strategy and plans to invest more in this area, although specific guidance was not provided [43][45]

Fourth Quarter & Full-Year 2024 Earnings Conference Call February 27, 2025 LGTMs: Date: Andrew T. LGTM via email 2/26/25 Peter K. LGTM 2/26/25 Legal (Karen / Peter R.) 2/26/25 Accounting (#s review) 2/25/2025 Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding Adjusted EBITDA, Adjusted Net i ...

Financial Performance - Full year 2024 GAAP Net loss from continuing operations improved by $164 million year-over-year, totaling a loss of $46 million[1] - Full year 2024 Adjusted EBITDA reached $70 million, an increase of $112 million year-over-year[1] - Total revenues for FY 2024 were $1.371 billion, an 8.8% increase from FY 2023[4] - Clover Health reported total revenues of $336.963 million for Q4 2024, a 7.4% increase from $312.385 million in Q4 2023[19] - Premiums earned, net for the year ended December 31, 2024, reached $1.344881 billion, compared to $1.235769 billion in 2023, reflecting an increase of 8.8%[19] - For the year ended December 31, 2024, Clover Health reported a net loss of $43,009 thousand, a significant improvement compared to a net loss of $213,361 thousand in 2023[21] - Adjusted EBITDA for the year ended December 31, 2024, was $70,091 thousand, compared to a loss of $41,555 thousand in 2023[27] - Total revenues for the year 2024 were $1,371,131 thousand, an increase from $1,260,543 thousand in 2023[25] Insurance Revenue and Membership Growth - Insurance revenue for Q4 2024 grew by 9% year-over-year to $331 million, and for the full year 2024, it reached $1.3 billion, also a 9% increase[2] - For full-year 2025, the company projects insurance revenue between $1.800 billion and $1.875 billion, representing a 37% growth year-over-year at the midpoint[6] - Average Medicare Advantage membership increased by 30% year-over-year, reaching between 103,000 and 107,000 for 2025[3] Expense Ratios and Claims - Insurance Benefits Expense Ratio (BER) improved to 82.8% in Q4 2024, down from 87.4% in Q4 2023[4] - The insurance benefits expense ratio (BER) for the year 2024 was 81.2%, an improvement from 86.5% in 2023[31] - The company incurred net medical claims of $243.044 million in Q4 2024, a slight decrease from $249.754 million in Q4 2023[19] - The insurance segment net loss for the year 2024 was $66,513 thousand, a reduction from a net loss of $199,508 thousand in 2023[23] Cash and Assets - Cash, cash equivalents, and investments totaled $437.6 million, a 4.9% increase from the previous year[4] - Clover Health's cash and cash equivalents increased to $194.543 million in 2024 from $116.407 million in 2023, representing a growth of 67%[17] - Clover Health's total assets increased to $580.742 million as of December 31, 2024, up from $570.671 million in 2023[17] - The total liabilities decreased to $239.599 million in 2024 from $284.277 million in 2023, indicating a reduction of approximately 15.7%[17] - Cash and cash equivalents at the end of the period increased to $194,543 thousand from $176,494 thousand at the end of 2023[21] - Net cash provided by operating activities from continuing operations for the year 2024 was $82,450 thousand, a turnaround from a cash used of $35,148 thousand in 2023[21] Company Strategy and Technology - The company plans to maintain strong profitability while investing in membership growth and Clover Assistant technology[2] - Clover Health's focus on technology, particularly the Clover Assistant platform, aims to enhance patient outcomes and reduce healthcare costs[14] Stock-Based Compensation - Stock-based compensation for the year 2024 was $114,331 thousand, down from $140,931 thousand in 2023[25] Definitions and Metrics - Adjusted EBITDA is defined as net loss from continuing operations before various expenses, providing a key measure for evaluating operating performance and trends[34] - Adjusted Net income (loss) from continuing operations excludes stock-based compensation and other non-recurring expenses, aiding in the assessment of financial performance[35] - Insurance Benefits Expense Ratio (BER) is calculated by dividing total insurance net medical expenses and quality improvements by premiums earned, offering insights into healthcare quality investments[36]

Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-year Company well positioned to invest in membership growth and Clover Assistant technology, while maintaining strong profitability Issues full year 2025 guidance: Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year at the midpointInsurance revenue between $1.800 billion ...

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [1] - The company's strategy is driven by its software platform, Clover Assistant, which aggregates patient data to support clinical decision-making and improve health outcomes through early identification and management of chronic diseases [1] Product and Services - Clover Health offers PPO and HMO Medicare Advantage plans across several states, with a particular emphasis on its flagship wide-network, high-choice PPO plans [1] - The company extends its data-driven technology platform to healthcare providers outside its Medicare Advantage plan through its subsidiary, Counterpart Health, aiming to enhance patient outcomes and reduce healthcare costs nationwide [1] Impact and Performance - Clover Health has published data showcasing the positive impact of its technology on Medication Adherence and the early identification and management of Diabetes and Chronic Kidney Disease [1] Investor Engagement - CFO Peter Kuipers will participate in the 2025 Jefferies Value-Based Healthcare Summit on March 10, 2025, and present at the 2025 Leerink Global Healthcare Conference on March 11, 2025 [2]

WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on February 27, 2025, to discuss Clover Health’s fourth quarter and full year 2024 business and financial results. Fourth Quarter and Full Year 2024 Conference Call and Webcast ...

Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well ...

Core Insights - Counterpart Health, Inc. has entered a strategic, multi-year agreement with Southern Illinois Healthcare (SIH) to enhance value-based care delivery through the integration of Counterpart Assistant, an AI-powered platform [1][2][4] - The partnership aims to improve patient outcomes by providing real-time, patient-specific insights within physicians' workflows, thereby simplifying the management of value-based care agreements [2][3] Company Overview - Counterpart Health is a subsidiary of Clover Health Investments, Corp. and focuses on AI-powered physician enablement [1][6] - The flagship product, Counterpart Assistant, has demonstrated improvements in clinical outcomes and plan performance for Medicare members through proprietary AI technology [6] Southern Illinois Healthcare (SIH) Overview - SIH is the largest health system in Southern Illinois, serving 16 counties with multiple hospitals and specialized care facilities [7][8] - The organization employs over 4,000 staff and is recognized for its commitment to providing charity care and community benefits totaling $1.3 billion since 2014 [8][9] Partnership Benefits - The integration of Counterpart Assistant into SIH's existing EPIC electronic health record system will allow clinicians to focus on patient care while meeting performance targets for value-based care [2][3] - The partnership is expected to enhance chronic disease management, streamline workflows, and facilitate earlier diagnoses, ultimately leading to better patient outcomes [3][4]

Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...